Many men feel shame due to ED.For some of the male subjects diagnosed with ED, participating in the study proved liberating. According to Prof. Herzl, one man in his 40s wept as he copulated. “He thought there was something wrong with him, and he was overcome with joy even as he made love,” said Prof. Herzl.
Other men in the study reevaluated their existing relationships. “My wife shamed me for ‘not being man enough,’” said 46-year-old James Hynes. “As it turns out she was just not attractive enough.” Hynes said that he has left his spouse and began dating online.
Others in the ED field find the study interesting but believe more studies are warranted. “I give a lot of credit to [Prof.] Herzl for his bold hypothesis and experimental methods,” said Harvard University professor of urology Matthew L. Warner, PhD. “But given the difficulty in ranking female attractiveness we need more studies to prove his concept.”
“As it turns out she was just not hot enough.”
Not all, however, are aroused. Most prominently, the study has deflated the aspirations of pharmaceutical companies to grow their ED drugs along with the aging population. Marvin Stiener, a Goldman Sachs pharmaceutical industry specialist, believes the industry’s ED bonanza may have climaxed. “Pfizer and Lilly have convinced men that if they have an old, ugly spouse or girlfriend that the problem is in between their legs,” said Stiener. “Once the full truth comes out the industry may experience a backlash that investors will find most deflating.”
A spokesperson for Pfizer noted that ED drugs help men achieve erections for their homely spouses no matter where the problem lies. “Let's not focus on the cause of the problem, but on the solution,” said Ed Bradley, Jr., spokesperson for Pfizer.